Investigation of the Genetic Association between Quantitative Measures of Psychosis and Schizophrenia: A Polygenic Risk Score Analysis

The presence of subclinical levels of psychosis in the general population may imply that schizophrenia is the extreme expression of more or less continuously distributed traits in the population. In a previous study, we identified five quantitative measures of schizophrenia (positive, negative, disorganisation, mania, and depression scores). The aim of this study is to examine the association between a direct measure of genetic risk of schizophrenia and the five quantitative measures of psychosis. Estimates of the log of the odds ratios of case/control allelic association tests were obtained f... Mehr ...

Verfasser: Derks, Eske M
Vorstman, Jacob AS
Ripke, Stephan
Kahn, Rene S
Ophoff, Roel A
Dokumenttyp: Artikel
Erscheinungsdatum: 2012
Reihe/Periodikum: PLOS ONE, vol 7, iss 6
Verlag/Hrsg.: eScholarship
University of California
Schlagwörter: Clinical Research / Human Genome / Schizophrenia / Genetics / Serious Mental Illness / Mental Health / Brain Disorders / Prevention / Aetiology / 2.3 Psychological / social and economic factors / 2.1 Biological and endogenous factors / Good Health and Well Being / Case-Control Studies / DNA / Genetic Predisposition to Disease / Genome / Human / Genome-Wide Association Study / Genotype / Humans / Multifactorial Inheritance / Netherlands / Phenotype / Polymerase Chain Reaction / Polymorphism / Single Nucleotide / Prognosis / Psychotic Disorders / Risk Factors / Schizophrenia Psychiatric Genomic Consortium / General Science & Technology
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-29158462
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://escholarship.org/uc/item/0zx981q9

The presence of subclinical levels of psychosis in the general population may imply that schizophrenia is the extreme expression of more or less continuously distributed traits in the population. In a previous study, we identified five quantitative measures of schizophrenia (positive, negative, disorganisation, mania, and depression scores). The aim of this study is to examine the association between a direct measure of genetic risk of schizophrenia and the five quantitative measures of psychosis. Estimates of the log of the odds ratios of case/control allelic association tests were obtained from the Psychiatric GWAS Consortium (PGC) (minus our sample) which included genome-wide genotype data of 8,690 schizophrenia cases and 11,831 controls. These data were used to calculate genetic risk scores in 314 schizophrenia cases and 148 controls from the Netherlands for whom genotype data and quantitative symptom scores were available. The genetic risk score of schizophrenia was significantly associated with case-control status (p<0.0001). In the case-control sample, the five psychosis dimensions were found to be significantly associated with genetic risk scores; the correlations ranged between.15 and.27 (all p<.001). However, these correlations were not significant in schizophrenia cases or controls separately. While this study confirms the presence of a genetic risk for schizophrenia as categorical diagnostic trait, we did not find evidence for the genetic risk underlying quantitative schizophrenia symptom dimensions. This does not necessarily imply that a genetic basis is nonexistent, but does suggest that it is distinct from the polygenic risk score for schizophrenia.